Harbor Capital Advisors Inc. Raises Stock Holdings in AdaptHealth Corp. (NASDAQ:AHCO)

Harbor Capital Advisors Inc. lifted its holdings in AdaptHealth Corp. (NASDAQ:AHCO) by 5.5% in the fourth quarter, HoldingsChannel reports. The firm owned 474,722 shares of the company’s stock after purchasing an additional 24,882 shares during the quarter. Harbor Capital Advisors Inc.’s holdings in AdaptHealth were worth $4,519,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. FMR LLC grew its stake in shares of AdaptHealth by 9.3% in the 3rd quarter. FMR LLC now owns 7,350,549 shares of the company’s stock worth $82,547,000 after buying an additional 624,645 shares in the last quarter. Reinhart Partners LLC. increased its stake in AdaptHealth by 45.2% during the third quarter. Reinhart Partners LLC. now owns 6,198,642 shares of the company’s stock worth $69,611,000 after acquiring an additional 1,929,339 shares during the last quarter. State Street Corp boosted its holdings in shares of AdaptHealth by 19.8% in the 3rd quarter. State Street Corp now owns 4,124,284 shares of the company’s stock worth $46,316,000 after purchasing an additional 681,816 shares during the period. Segall Bryant & Hamill LLC increased its position in shares of AdaptHealth by 15.5% during the 3rd quarter. Segall Bryant & Hamill LLC now owns 3,701,808 shares of the company’s stock valued at $41,571,000 after purchasing an additional 496,453 shares during the last quarter. Finally, Geode Capital Management LLC raised its holdings in AdaptHealth by 12.2% during the 3rd quarter. Geode Capital Management LLC now owns 2,451,173 shares of the company’s stock valued at $27,532,000 after buying an additional 265,712 shares during the period. Institutional investors own 82.67% of the company’s stock.

Analyst Ratings Changes

AHCO has been the topic of a number of analyst reports. Royal Bank of Canada cut their price objective on shares of AdaptHealth from $13.00 to $11.00 and set an “outperform” rating on the stock in a research report on Tuesday, November 19th. Truist Financial reduced their price objective on shares of AdaptHealth from $13.00 to $12.00 and set a “buy” rating on the stock in a research report on Friday, November 15th. Robert W. Baird dropped their target price on AdaptHealth from $16.00 to $14.00 and set an “outperform” rating for the company in a research report on Wednesday, November 6th. UBS Group reduced their price target on AdaptHealth from $13.00 to $12.00 and set a “buy” rating on the stock in a report on Wednesday, November 6th. Finally, Canaccord Genuity Group dropped their price objective on AdaptHealth from $14.00 to $13.00 and set a “buy” rating for the company in a report on Wednesday, November 6th. Five analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average target price of $12.40.

AdaptHealth Stock Up 0.4 %

NASDAQ:AHCO opened at $10.14 on Friday. The company has a debt-to-equity ratio of 1.34, a current ratio of 1.24 and a quick ratio of 1.00. The firm has a market cap of $1.36 billion, a PE ratio of -6.15, a price-to-earnings-growth ratio of 1.36 and a beta of 1.09. The company has a 50-day moving average of $9.86 and a 200 day moving average of $10.32. AdaptHealth Corp. has a 1-year low of $6.46 and a 1-year high of $11.90.

AdaptHealth (NASDAQ:AHCO) last issued its quarterly earnings data on Tuesday, November 5th. The company reported $0.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.17 by ($0.02). The business had revenue of $805.90 million for the quarter, compared to analysts’ expectations of $809.32 million. AdaptHealth had a negative net margin of 6.57% and a positive return on equity of 9.62%. The business’s quarterly revenue was up .2% compared to the same quarter last year. During the same period in the previous year, the business earned $0.19 earnings per share. As a group, research analysts anticipate that AdaptHealth Corp. will post 0.88 EPS for the current fiscal year.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.